Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Treasury Shares (2023 - 2025)

Connect Biopharma Holdings' Treasury Shares history spans 2 years, with the latest figure at $2.5 million for Q4 2024.

  • For Q3 2025, Treasury Shares changed N/A year-over-year to $180000.0; the TTM value through Sep 2025 reached $180000.0, changed N/A, while the annual FY2024 figure was $180000.0, 0.0% changed from the prior year.
  • Treasury Shares for Q3 2025 was $180000.0 at Connect Biopharma Holdings, roughly flat from $180000.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $2.5 million in Q4 2024 and bottomed at $2.4 million in Q4 2023.
  • The 3-year median for Treasury Shares is $180000.0 (2023), against an average of $180000.0.
  • The largest YoY upside for Treasury Shares was 0.0% in 2024 against a maximum downside of 0.0% in 2024.
  • A 3-year view of Treasury Shares shows it stood at $180000.0 in 2023, then changed by 0.0% to $180000.0 in 2024, then changed by 0.0% to $180000.0 in 2025.
  • Per Business Quant, the three most recent readings for CNTB's Treasury Shares are $180000.0 (Q3 2025), $180000.0 (Q2 2025), and $180000.0 (Q1 2025).